Targeting BRCA2 deficiency with GSK3 inhibitors
<p>BRCA1 and BRCA2 tumour suppressors are essential for homologous recombination-mediated double-strand break repair and replication fork protection. Therefore, BRCA1 and BRCA2 are essential for cell viability. Deactivating mutations in one of these genes lead to genome instability and are ass...
Yazar: | Zonderland, G |
---|---|
Diğer Yazarlar: | Tarsounas, M |
Materyal Türü: | Tez |
Baskı/Yayın Bilgisi: |
2017
|
Benzer Materyaller
-
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Yazar:: Tacconi, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019) -
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
Yazar:: Eliana MC Tacconi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01) -
Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds
Yazar:: Zimmer, J, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
Targeting the BRCA1/2 deficient cancer with PARP inhibitors: Clinical outcomes and mechanistic insights
Yazar:: Ashwin Ragupathi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01) -
Novel approaches for targeting BRCA2-deficient tumour cells
Yazar:: Tacconi, E
Baskı/Yayın Bilgisi: (2015)